UK Biotech Startup Ventures to Challenge Weight Loss Giants Novo and Lilly

A new player has entered the weight loss arena, taking aim at pharmaceutical powerhouses such as Novo Nordisk and Eli Lilly. This innovative UK biotech startup has unveiled ambitious plans to develop treatment alternatives that could potentially disrupt the current market dominated by these industry leaders.

Continue reading